Next Article in Journal
Mapping Canadian Data Assets to Generate Real-World Evidence: Lessons Learned from Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration’s RWE Data Working Group
Previous Article in Journal
The Role of the 21-Gene Recurrence Score® Assay in Hormone Receptor-Positive, Node-Positive Breast Cancer: The Canadian Experience
 
 
Article

Article Versions Notes

Curr. Oncol. 2022, 29(3), 2021-2045; https://doi.org/10.3390/curroncol29030164
Action Date Notes Link
article xml file uploaded 17 March 2022 09:16 CET Original file -
article xml uploaded. 17 March 2022 09:16 CET Update -
article pdf uploaded. 17 March 2022 09:16 CET Version of Record https://www.mdpi.com/1718-7729/29/3/164/pdf-vor
article html file updated 17 March 2022 09:17 CET Original file -
article xml file uploaded 18 March 2022 02:41 CET Update -
article xml uploaded. 18 March 2022 02:41 CET Update https://www.mdpi.com/1718-7729/29/3/164/xml
article pdf uploaded. 18 March 2022 02:41 CET Updated version of record https://www.mdpi.com/1718-7729/29/3/164/pdf
article html file updated 18 March 2022 02:43 CET Update -
article html file updated 1 August 2022 06:07 CEST Update https://www.mdpi.com/1718-7729/29/3/164/html
Back to TopTop